Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the efficacy, safety, and tolerability of apremilast for early oligoarticular psoriatic arthritis; the study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Otezla (apremilast) (apremilast)

Snippet

Sponsor: Amgen | Conditions: Arthritis, Psoriatic | Phase 4 | Status: COMPLETED | Results posted: 2024-01-05